Marhaba partners with PRIME Health to provide world-class travel services for Dubai's medical tourists
Dubai, UAE – marhaba, part of dnata and a leading global airport hospitality brand, has partnered with PRIME Health to provide premium travel services for passengers arriving in Dubai for medical treatment.
Driven by a commitment to patient well-being, the partnership ensures a smooth and stress-free travel experience that complements the quality of care provided by PRIME Health.
marhaba will provide its full airport hospitality offering to support medical travellers, including its signature Meet & Greet, Chauffeur and Lounge services. In addition, its recently announced Check-in Anywhere and Land & Leave solutions will further enhance the journey, enabling a smooth, hands-free experience from arrival to departure.
Jaffar Dawood, dnata's Divisional Senior Vice President - UAE Airport Operations, said: 'We are pleased to partner with PRIME Health to further enhance the medical tourism experience in Dubai. With marhaba's personalised service and Arabian hospitality, twinned with Dubai's world-class infrastructure, we ensure medical travellers feel looked after from the moment they land. This partnership reflects our shared focus on care, comfort and service excellence.'
Dr. Jamil Ahmed, Founder and Managing Director, PRIME Health, said: 'At PRIME Health, we believe exceptional care starts well before a patient enters the hospital. Our partnership with marhaba ensures international patients receive a warm, stress-free welcome the moment they land. By combining world-class hospitality with trusted medical expertise, we are redefining the healthcare journey making it as seamless and supportive as possible from arrival to recovery.'
Dubai welcomed over 691,000 people for medical treatments in 2023, with spending on healthcare services exceeding AED 1.03 billion (US$ 280 million). The emirate is rapidly positioning itself as a leading global destination for medical tourism, combining advanced healthcare with world-class luxury and personalised care.
According to PRIME Health, international patient flows to Dubai have grown across diverse medical specialisms, with dentistry, dermatology, cardiology, and fertility treatments leading demand. Medical tourists increasingly seek Dubai's orthopaedic treatments, particularly joint replacement surgeries, and the city's range of the latest cosmetic treatments also remain popular with visitors.
As part of its growing network, PRIME Health also operates medical centres within terminals one and three at Dubai International airport (DXB), providing convenient access to high-quality care for travellers.
marhaba, which means 'welcome' in Arabic, was launched in the UAE to help passengers arriving in or departing from Dubai International airport. The popularity of meet & greet services has grown exponentially in line with Dubai's growth as a major international travel hub, and marhaba has continually expanded its product offering with a growing list of services and extra options designed to make the passenger airport experience as comfortable as possible.
The marhaba brand is part of dnata, one of the world's largest air services providers. A trusted partner of over 300 airline customers, dnata offers ground handling, cargo, travel catering & retail services in over 30 countries across six continents.
Contact
marhaba Public Relations
public.relations@dnata.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
an hour ago
- Zawya
FOCP's ‘Pink October' encourages corporates and institutions to participate in Breast Cancer Awareness month
Pink October focuses on early breast cancer detection and awareness. It offers free mammogram screenings and clinical breast examinations through mobile clinics. The initiative provides educational sessions and workshops on breast self-examination for both women and men. Corporate participation is encouraged through tailored packages, including mobile clinic bookings and Corporate Wellness Days. The campaign aims to empower communities, reduce breast cancer rates, and promote proactive health checks. Sharjah: The Friends of Cancer Patients (FOCP) has launched its Pink October campaign to promote early breast cancer detection through community education and accessible screening programs. The campaign, delivered through FOCP's Pink Caravan initiative, aims to raise awareness and ensure individuals have the knowledge and resources necessary to prioritise their breast health To provide tailored support and awareness to the UAE workforce, FOCP encourages companies and institutions across the nation to play a crucial role in the ongoing fight against breast cancer by partnering with the Pink Caravan and making its vital services accessible to their employees. Social responsibility and awareness Corporate participation is essential in amplifying the reach and impact of breast cancer awareness efforts. By partnering with the Pink Caravan initiative, companies can demonstrate their commitment to social responsibility and actively contribute to enhancing the health and well-being of women and men in the workplace. 'Early detection saves lives and it's a responsibility we all share,' said Aisha Al Mulla, Director of FOCP. 'In the UAE, companies and corporations are pillars of our community, so their platforms, networks, and influence can play a transformative role in promoting awareness, encouraging screenings, and supporting a culture of proactive health. Through our Pink October campaign, we urge business leaders and industry decision-makers to step up, speak out, and join us in championing the importance of early detection. Together, we can build a healthier, stronger, and more resilient society.' Tailored options for corporate and institutional entities This year's Pink October campaign offers a range of tailored solutions to encourage corporate involvement, designed to make participation impactful and effective. Companies can book Pink October's mobile clinic to visit their premises, providing expert-led mammogram screenings for female employees aged 40 and above, as well as clinical breast examinations for women and men aged 20 and above. These services are delivered with the utmost professionalism and privacy, ensuring a comfortable and supportive experience for all participants. For organisations seeking a comprehensive approach to employee health, the Pink October Corporate Wellness Day is ideal, combining clinical breast examination, mammogram vouchers, and engaging awareness lectures that empower staff with life-saving knowledge. In addition to these core offerings, companies can also benefit from Mini Mobile Clinics, which provide screening services at the workplace. They can also book awareness seminars and workshops, available both onsite and online. These educational sessions are designed for both women and men, covering the essentials of breast self-examination and the importance of early detection. They are complemented by informative brochures distributed to all attendees. The impact of Pink Caravan and their Pink October campaign is clear, and year after year, thousands of women and men across the UAE gain access to screenings and educational resources, thanks to the support of forward-thinking corporate partners. Corporate bookings for the Pink October campaign are now open, and to reserve your Mobile Clinic, Corporate Wellness Day, or Awareness Seminar, simply email the Pink October team at info@
Khaleej Times
2 hours ago
- Khaleej Times
Future Health GCC Stem Cell Bank launches in-house GMP exosome production facility
Future Health GCC Stem Cell Bank, a recognised leader in stem cell banking and cellular science, has officially launched its new, in-house GMP (Good Manufacturing Practice) exosome production facility at its premises in Dubai Healthcare City. This milestone marks a significant advancement in the company's ongoing efforts to enhance its capabilities in biological processing and life sciences innovation. The newly developed facility enables Future Health GCC to produce GMP-compliant exosome preparations under strict international quality standards. This infrastructure supports a wide range of scientific and research-focused applications, reinforcing the company's position as a technology-forward organisation in the region. Exosomes, which are naturally occurring vesicles secreted by cells, are currently being explored globally for their role in intercellular communication and potential applications in research and biotechnology. Future Health GCC's initiative reflects its commitment to supporting this growing area of scientific study. 'The launch of our GMP exosome production facility is a key milestone that showcases our continuous investment in high-standard, advanced technologies,' said Ahmad Al Ahmad, CEO of Future Health GCC Stem Cell Bank. 'With this addition, we are proud to contribute to the development of the region's biotech infrastructure and facilitate future regenerative medicine' The facility is designed to accommodate scalable exosome production from various cell sources, with processes adhering to international GMP standards. All production batches are handled within tightly controlled environments, and finished products are stored in ultra-low temperature freezers at -80°C, monitored through a cloud-based temperature control system to ensure product consistency and integrity. The new facility will also enable collaboration opportunities with research institutions, biotech startups, and academic entities seeking reliable, quality-controlled exosome products for non-clinical and investigational use.
Khaleej Times
3 hours ago
- Khaleej Times
NMC Royal Hospital DIP revolutionising breast cancer surgery in the UAE with Sentimag system
The Sentimag system offers a breakthrough alternative by replacing radioactive tracers and blue dye with a safe, non-radioactive technique In a significant advancement for breast cancer treatment in the UAE, NMC Royal Hospital DIP has successfully performed its first breast cancer surgery using the Sentimag system, a cutting-edge, radiation-free technology for sentinel lymph node localisation, marking a major milestone in surgical innovation in the country. The procedure, a first across the entire NMC Healthcare network, was performed at the hospital's dedicated Breast Cancer Clinic by Dr Afaf Sahraoui, specialist in breast, thyroid, and parathyroid surgery, and certified by the Norwegian Health Board. The Sentimag system replaces the conventional use of radioactive tracers and blue dye with a safe, magnetic alternative, enhancing both patient safety and surgical precision. In modern surgical breast cancer surgery, sentinel lymph node biopsy is a crucial step used to determine whether cancer has spread beyond the tumour. Traditionally, this process involves the use of radioactive isotopes and blue dye to locate sentinel lymph nodes which are methods that can pose risks such as radiation exposure, potential allergic reactions and complex logistical challenges due to strict timing of tracer injections. The Sentimag system offers a breakthrough alternative by replacing radioactive tracers and blue dye with a safe, non-radioactive technique. It uses Magtrace, a liquid solution containing magnetic nanoparticles administered before surgery. During the procedure, a handheld probe is used to detect magnetic signals and accurately locate and remove the sentinel lymph node. The same system can also deploy Magseed, a tiny magnetic marker used to localise nonpalpable breast tumours (those not detectable by touch), eliminating the need for traditional guidewires. The first patient to undergo surgery using Sentimag at NMC Royal Hospital DIP was a 47-year-old woman diagnosed with a 26mm invasive breast carcinoma, a malignant tumour that had spread beyond the breast tissue. Following evaluation by a multidisciplinary tumour board, she was recommended for breast-conserving surgery with sentinel lymph node biopsy using the Sentimag system. As the tumour was palpable, Magtrace alone was sufficient, and the procedure was successfully completed through a minimally invasive incision, with the sentinel nodes accurately identified and removed without complications. The technique significantly reduced recovery time, with the patient experiencing minimal discomfort and was discharged just six hours after surgery. She also showed excellent recovery at her one-week postoperative follow-up with no signs of infection. "This technology offers a safer, more convenient, and patient-friendly advancement in breast cancer surgery," said Dr Afaf Sahraoui. "By eliminating the use of radiation and blue dye, we're not only reducing risks but also simplifying the surgical process without compromising diagnostic accuracy. It's a significant step forward for women's health in the UAE." "Sentimag revolutionises sentinel lymph node surgery with a precise, radiation-free alternative,' added Dr Shaista Meraj, consultant radiologist. 'It expands patient access particularly in units like ours, without on-site radioisotopes. This ensures breast clinic efficiency by providing a sustainable and patient friendly alternative to radioactive tracer." The introduction of the Sentimag system reinforces NMC Royal Hospital DIP's commitment to innovation and patient-centred care, making it one of the first hospitals in Dubai to offer this advanced, radiation-free solution for breast cancer surgery. This breakthrough strengthens the hospital's Breast Cancer Clinic offering and reflects NMC Healthcare's ongoing dedication to providing world-class evidence-based treatments to patients across the country.
